MADISON, Wis.--(BUSINESS WIRE)--Researchers and thought leaders who investigate the potential of psychedelic therapies, including Dr. Robin Carhart-Harris, Head of Psychedelic Research at Imperial College London, will engage in a compelling exploration of “Psychedelic Therapy in Society: Exploring the Mechanisms of Action and Delivery of Care” at the 18th International Forum on Consciousness May 16-17, 2019, in Madison, WI.
The latest research in psychedelic therapy suggests the potential for a paradigm shift in how we approach treatment of depression, anxiety and certain forms of mental anguish. Academic research shows that a single dose in combination with preparation and follow-up could have an impact long after the substance has left the body. Questions remain around what exactly happens in the brain that facilitates such a transformation and how treatment of this nature can scale to meet dramatic need.
Find abstracts, schedules, speaker information and more at btci.org/forum.
- What: 2019 International Forum on Consciousness – “Psychedelic Therapy in Society: Exploring the Mechanisms of Action and Delivery of Care”
- When: May 16-17, 2019
- Where: The BioPharmaceutical Technology Center on the Promega Campus, 5445 East Cheryl Parkway, Fitchburg, WI 53711
- Who: Open to the general public, but limited to 300 participants
- Registration: Pre-registration is required. Click here or visit btci.org/forum.
The International Forum on Consciousness is a yearly event dedicated to information-sharing and discussion regarding important—and often challenging—topics related to the exploration of consciousness. It is co-hosted by the BioPharmaceutical Technology Center Institute (BTC Institute) and Promega Corporation. View videos of previous Forums here.
2019 Presenters:
- Heidi L. Allen, Ph.D., Associate Professor, School of Social Work, Columbia University, New York, NY
- Robin L. Carhart-Harris, Ph.D., Head of Psychedelic Research, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faulty of Medicine, Imperial College London, London, United Kingdom
- Tania de Jong, AM, Singer, Speaker, Social Entrepreneur; Founder Mind Medicine Australia, Creative Universe, Creative Innovation Global and Creativity Australia, South Melbourne, Victoria, Australia
- Adam Halberstadt, Ph.D., Assistant Adjunct Professor, Department of Psychiatry, University of California San Diego, La Jolla, CA
- Jack Henningfield, Ph.D., Vice President, Research, Health Policy and Abuse Liability, Pinney Associates, Bethesda, MD & Professor, Adjunct, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD.
- John D. McCorvy, Ph.D., Assistant Professor, Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI
- Stevens Rehen, Ph.D., Chief of Scientific Programs and Outreach, D’Or Research and Education Institute (IDOR); Full Professor, Biomedical Sciences Institute, Universidad e Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- Will Siu, M.D., DPhil, Psychiatrist, New York, NY
- Craig A. Vercruysse, MBA, Partner, Moss Adams, San Francisco Bay Area, CA
- Bennet A. Zelner, Ph.D., Associate Professor, Robert H. Smith School of Business. University of Maryland, College Park, MD
About the BTC Institute
The BTC Institute is a not-for-profit organization operated exclusively for educational, scientific and cultural purposes. Learn more about its K–12 programs, scientific course offerings, and annual educational forums and symposia at btci.org.
